Telix Pharmaceuticals Limited (ASX: TLX)
Australia
· Delayed Price · Currency is AUD 18.32
-0.03 (-0.16%)
Jul 3, 2024, 4:10 PM AEST
Telix Pharmaceuticals Market Cap
Telix Pharmaceuticals has a market cap or net worth of 6.12 billion as of July 3, 2024.
Market Cap
6.12B
Enterprise Value
5.97B
Revenue
502.55M
Ranking
n/a
PE Ratio
922.00
Stock Price
18.32
Market Cap Chart
Since December 31, 2017, Telix Pharmaceuticals's market cap has increased from 83.20M to 6.12B, an increase of 7,259.87%. That is a compound annual growth rate of 93.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 3, 2024 | 6.12B | 90.32% |
| Dec 31, 2023 | 3.22B | 42.46% |
| Dec 31, 2022 | 2.26B | 3.26% |
| Dec 31, 2021 | 2.19B | 124.90% |
| Dec 31, 2020 | 972.48M | 168.77% |
| Dec 31, 2019 | 361.83M | 175.40% |
| Dec 31, 2018 | 131.38M | 57.92% |
| Dec 31, 2017 | 83.20M | - |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 141.57B |
| ResMed Inc. | 41.74B |
| Cochlear Limited | 20.70B |
| Fisher & Paykel Healthcare Corporation Limited | 15.82B |
| Pro Medicus Limited | 14.21B |
| Sonic Healthcare Limited | 12.28B |
| Ramsay Health Care Limited | 10.56B |
| Neuren Pharmaceuticals Limited | 2.53B |